Autologous microvesicles of erythrocyte plasmalemma were obtained by means of ultrasound treatment of erythrocyte suspension. These microvesicles were intravenously (i.v.) injected to pregnant rabbits with artificial bleeding at the 21st day of gestation. Three i.v. injections of microvesicles with 1-3 day interval at the amount equal to 1% of the weight of the circulating erythrocyte plasmalemma increased almost to the control level the number of erythrocytes and hemoglobulin by the 8th day after the bleeding while these indices were much lower in untreated animals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

microvesicles erythrocyte
8
erythrocyte plasmalemma
8
[stimulation erythropoiesis
4
erythropoiesis hemorrhage
4
hemorrhage pregnancy
4
microvesicles
4
pregnancy microvesicles
4
erythrocyte
4
erythrocyte plasmolemma]
4
plasmolemma] autologous
4

Similar Publications

Introduction: Large-volume packed red blood cell (pRBC) transfusion is associated with lung injury and worsened outcomes. Amitriptyline reduces lung injury and inflammation in a murine sepsis model. We hypothesized that red cell microparticles (MP) activate endothelial cells, leading to lung injury and that treatment with amitriptyline would blunt the inflammatory response MPs through inhibition of acid sphingomyelinase (ASM).

View Article and Find Full Text PDF

Introduction: The red blood cell (RBC) storage lesion has been well described in mouse and human blood but not in swine. Understanding the porcine RBC storage lesion is necessary prior to evaluating transfusion of stored packed red blood cells (pRBCs) in polytrauma models. We hypothesized that porcine pRBCs would undergo a similar storage lesion severity after 42 d.

View Article and Find Full Text PDF

Promoted coagulant activity and disrupted blood-brain barrier depending on phosphatidylserine externalization of red blood cells exposed to ZnO nanoparticles.

Environ Pollut

December 2024

College of Pharmacy Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, 15588, Republic of Korea. Electronic address:

Article Synopsis
  • Zinc oxide nanoparticles (ZnO-NPs) are widely used nanomaterials that can enter the bloodstream, raising concerns about their impact on cardiovascular health.
  • The study found that ZnO-NPs can increase clotting activity in red blood cells and disrupt the blood-brain barrier by promoting the engulfment of these cells by brain endothelial cells.
  • These effects suggest that ZnO-NPs could pose potential risks for thrombosis and cardiovascular dysfunction, highlighting the need for further investigation into their safety.
View Article and Find Full Text PDF

Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles.

Carbohydr Polym

November 2024

State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400715, China; Department of Geriatric Medicine, Wenzhou Ouhai District Chinese and Western Medical Association Hospital, Wenzhou 325000, China. Electronic address:

The development of thrombolytic drug carriers capable of thrombus-targeting, prolonged circulation time, intelligent responsive release, and the ability to inhibit thrombotic recurrences remains a promising but significant challenge. To tackle this, an artificial polysaccharide microvesicle drug delivery system (uPA-CS/HS@RGD-ODE) was constructed. It is composed of cationic chitosan and anionic heparin assembled in a layer by layer structure, followed by surface modification using RGD peptide and 2-(N-oxide-N,N-diethylamino) ethylmethacrylate (ODE) before encapsulation of urokinase-type plasminogen activator (uPA).

View Article and Find Full Text PDF

Background: The study aimed to determine the most crucial parameters associated with CVD and employ a novel data ensemble refinement procedure to uncover the optimal pattern of these parameters that can result in a high prediction accuracy.

Methods And Results: Data were collected from 369 patients in total, 281 patients with CVD or at risk of developing it, compared to 88 otherwise healthy individuals. Within the group of 281 CVD or at-risk patients, 53 were diagnosed with coronary artery disease (CAD), 16 with end-stage renal disease, 47 newly diagnosed with diabetes mellitus 2 and 92 with chronic inflammatory disorders (21 rheumatoid arthritis, 41 psoriasis, 30 angiitis).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!